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Abstract 
Purpose: This study aimed to further explore the mechanisms behind the ability of certain 
linear polyamidoamines (PAAs) to transfect cells with minimal cytotoxicity.  
Methods: The transfection efficiency of DNA complexed with a PAA of a molecular weight 
over 10 kDa or 25 kDa branched polyethyleneimine (BPEI) was compared in A549 cells using 
a luciferase reporter gene assay. The impact of endo/lysosomal escape on transgene expression 
was investigated by transfecting cells in presence of bafilomycin A1 or chloroquine. 
Cytotoxicity caused by the vectors was evaluated by measuring cell metabolic activity, lactate 
dehydrogenase release, formation of reactive oxygen species and changes in mitochondrial 
membrane potential.  
Results: The luciferase activity was 3-fold lower after transfection with PAA polyplexes than 
with BPEI complexes at the optimal polymer to nucleotide ratio (RU:Nt). However, in contrast 
to BPEI vectors, PAA polyplexes caused negligible cytotoxic effects. The transfection 
efficiency of PAA polyplexes was significantly reduced in presence of bafilomycin A1 while 
chloroquine enhanced or decreased transgene expression depending on the RU:Nt.  
Conclusions: PAA polyplexes displayed a pH-dependent endo/lysosomal escape which was 
not associated with cytotoxic events, unlike observed with BPEI polyplexes. This is likely due 
to their greater interactions with biological membranes at acidic than neutral pH.  
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Abbreviations 
BPEI: branched poly(ethyleneimine); EtBr: Ethidium bromide; FCCP: Carbonyl cyanide 4-
(trifluoromethoxy) phenylhydrazone; H2DCFH-DA: 2′,7′-dichlorodihydrofluorescein 
diacetate; JC-1: 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolyl-carbocyanine iodide; 
LDH: Lactate dehydrogenase; MBA-DMEDA: 
methylenebisacrylamide/dimethylethylenediamine; MTT: 3-[4,5-Dimethylthiazol-2-yl]-2,5-
diphenyl tetrazolium bromide; MMP: Mitochondrial membrane potential; PAA: 
Polyamidoamine; PB: PrestoBlue; PBS: Phosphate buffer saline; pDNA: plasmid DNA; PEG: 
polyethylene glycol; PEI: poly(ethyleneimine); PLL: poly-L-lysine; ROS: Reactive oxygen 
species; RU:Nt: Polymer repeating unit to nucleotide ratio. 
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Introduction 
One of the greatest challenges in gene therapy remains the development of safe and effective 
vehicles to deliver fragile exogenous nucleic acids into host cells. A handful of gene therapies 
based on viral vectors  have been granted market approval in the European Union or United 
States; i.e., Glybera® (uniQure N.V.), Imlygic® (Amgen Inc), StrimvelisTM (GlaxoSmithKline), 
KymriahTM (Novartis). Nevertheless, the clinical applications of such vectors is impeded by 
major concerns surrounding their potential immunogenicity and insertional mutagenesis (1). 
To overcome those limitations, non-viral vectors using either cationic lipids or cationic 
polymers, which can readily complex with the negatively charged phosphate bases in 
nucleotides, have been investigated intensively as alternative gene delivery systems (2, 3).   
Due to the ease of manufacture and low cost of cationic polymers, their development as carriers 
for gene therapy is attracting a lot of interest, with extensive work being carried out using 
polyethyleneimine (PEI) or poly-L-lysine (PLL).  Safety remains nevertheless an issue as 
cationic vectors may bind non-specifically to negatively charged blood components and be 
recognised by phagocytotic cells, which could trigger an immune response in addition to 
decreasing their circulation time in blood (4,5).  At the cellular level, both PEI and PLL have 
been shown to trigger staged cytotoxic events. Early deleterious effects occur due to the 
destabilisation of the plasma membrane by the polymers and delayed toxicity is caused by the 
induction of the apoptosis process following polymer disruption of mitochondrial functions 
(6).  
A vast range of structural modifications have been designed to improve the biocompatibility 
of cationic polymers (4). However, in many cases, a relationship is observed between the level 
of gene expression achieved and the toxicity of the vectors (7, 8). For instance, increasing the 
molecular weight of the polymers usually enhances transgene expression but is associated with 
more pronounced detrimental effects (5, 9). Similarly, grafting a hydrophilic non charged 
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macromolecule such as polyethylene glycol (PEG) onto cationic polymers to shield the vector 
surface charge has been shown to have a positive effect on their in vivo toxicity profile (10) 
but can negatively affect their transfection efficiency due to decreased cell uptake and/or 
endosomal escape (11, 12) 
Mechanistic studies suggest that the transfection efficiency and cytotoxicity of cationic vectors 
both originate from polymer interactions with biological membranes (7, 8). Polyplexes need to 
overcome several cellular barriers to deliver genetic materials to the cytoplasm or nuclei. It is 
generally acknowledged that polyplexes enter the cells by endocytotic processes, implying that 
their escape from the endosomes before degradation in the lysosomes is a critical step in 
achieving transfection (5). Permeabilization of the plasma, endosomal or nuclear membranes 
by the polymer will promote gene expression but also pro-apoptotic events. Dissociating the 
beneficial effects of cationic polymers from their toxicity therefore constitutes a major 
challenge.  
Linear polyamidoamines (PAAs) are a group of biodegradable cationic polymers that have 
more recently been explored as gene delivery systems. Interestingly, some of those polymers 
exhibit a transfection efficiency similar to that obtained with PEI but with a low cytotoxicity 
compared to other polycationic vectors (13-16). Their cellular adverse effects have 
nevertheless only been probed in assays indirectly measuring the cell metabolic activity based 
on the reduction of tetrazolium salts into coloured formazan derivatives by mitochondrial 
enzymes such as the MTT, MTS or XTT assays. There is therefore a need for a deeper insight 
into their cytotoxic profile before their potential as delivery agents in gene therapy can be fully 
appreciated. Furthermore, the intracellular fate of PAA polyplexes remains unclear to date, 
prompting questions around the mechanisms underlying their ability to mediate gene transfer.  
The present work explored cellular events induced by DNA polyplexes prepared using a linear 
PAA with a methylenebisacrylamide/dimethylethylenediamine (MBA-DMEDA) backbone of 
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a molecular weight over 10kDa. Amongst a series of structurally diverse PAAs, MBA-
DMEDA based polymers showed the greatest ability to complex DNA as well as to promote 
transgene expression (17), with a similar transfection ability as the ISA group of PAAs 
described elsewhere (18). Hence, the MBA-DMEDA structure was selected for this study 
which aimed to confirm and better understand the absence of relationship between cytotoxicity 
and transfection efficiency reported with certain PAA vectors. Polyplexes made with a 
commercially available branched PEI (BPEI) of 25kDa known to be highly efficient as a gene 
delivery vehicle but also highly toxic (19) were tested alongside for comparison.  
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Experimental Methods 
Materials   
The PAA used in this study was based on co-monomers of MBA-DMEDA where 21% of the 
aminic component was replaced by a mono-boc-protected cystamine converted to a 
dithiopyridyl protecting group (20) (Figure 1). Due to the low solubility of this polymer, it was 
not possible to determine its molecular weight and pKa values. Nevertheless, the parent 
polymer without the dithiopyridyl pendant groups exhibited a molecular weight of 
approximately 10 kDa with a polydispersity M w /M n of 1.4, as determined by size exclusion 
chromatography. Furthermore, its pKa1 and pKa2 values were measured as 4.89 ± 0.03 and 8.45 
± 0.05, respectively (21). The polymer was ultrafiltered through a Millipore® ultrafiltration 
membrane with a 10kDa nominal molecular weight cut-off (Merck, Darmstadt, Germany) to 
remove polymer chains with a molecular weight below this value.  
The gWiz- LUC plasmid (pDNA; 6.7 kbp) encoding a firefly luciferase reporter gene was 
obtained from Aldevron (Fargo, USA). Lactate dehydrogenase (LDH) assay kit (CytoTox-
ONE™), bright-Glo™ Luciferase Assay system and Glo Lysis Buffer (1X) were purchased 
from Promega (Southampton, UK). PrestoBlue® Cell Viability Reagent, DNA Gel Loading 
Dye (6X) and Tris-Acetate-EDTA (TAE) buffer were obtained from Fisher Scientific 
(Loughborough, UK). 2′,7′-dichlorodihydrofluorescein diacetate (H2DCFH-DA) and 
OptiMEM® I Reduced Serum Medium were purchased from Invitrogen (Thermo Fisher 
Scientific, Waltham, MA, USA). 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolyl-
carbocyanine iodide (JC-1) was obtained from Biotium (Fremont, CA, USA). Bafilomycin A1 
was purchased from Alfa Aesar (Fisher Scientific, Loughborough, UK). 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT), Carbonyl cyanide 4-
(trifluoromethoxy) phenylhydrazone (FCCP), BPEI (25 kDa), ethidium bromide (EtBr, 
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1mg/ml solution), Coomassie Brilliant Blue R250, agarose powder and all other chemicals or 
cell culture reagents were purchased from Sigma-Aldrich (Gillingham, UK). 
Preparation of DNA polyplexes 
DNA polyplexes were prepared by the addition of polymer solutions to nucleic acid solutions 
in 5mM phosphate buffer saline (PBS). The amount of polymer required to produce the 
polyplexes was calculated by using the following equation:     
Amount of Polymer = Polymer RU Molecular Weight /DNA RU Molecular Weight X Polymer 
to Nucleotide Ratio X Amount of DNA 
with RU = repeating units   
Equal volumes of polymer and nucleic acid solutions were mixed together. The polymer- DNA 
mixture was vortexed, then incubated at room temperature for 30 min upon which the 
polyplexes spontaneously formed.   
Gel retardation assay 
Polyplexes containing 1μg of DNA were prepared as described above to obtain polymer to 
nucleotide (RU:Nt) ratios ranging from 1:1 to 10:1 for PAA and from 1:1 to 50:1 for BPEI. 5 
mM PBS (pH 7.4) was added to the polyplex preparation to give a total volume of 20 μl. 
Complexes were mixed with the DNA Gel Loading Dye (6X) (2.5µl) and loaded onto agarose 
gels 1% in 1 x TAE buffer containing ethidium bromide (EtBr, 1µg/ml). Free DNA and free 
polymers were also applied onto the same gels. The gels were allowed to run at 80 V for 60 
min in TAE buffer. Free, semi or completely bound nucleic acids were visualised using an UV-
transilluminator gel imaging system (The Bioimaging Company UK) by using the Syngene 
software. For visualization of the free polymers, the gels were stained with Coomassie Blue 
0.1% w/v in 50% methanol and 10% glacial acetic acid for one hour followed by 24 h in a 
9 
 
destaining solution made of 10% v/v methanol and 10% v/v glacial acetic acid. Images were 
taken under white light using the same imaging software. 
Particle size and zeta-potential measurements 
The size of the polyplexes was measured by Dynamic Light Scattering (DLS) using a Viskotek 
DLS 802 at 25 ºC and a fixed scattering angle of 90º. Their zeta potential was determined using 
a Zetasizer Nano Series (Malvern, UK).   
Cell culture 
The human lung adenocarcinoma A549 cell line was purchased from the American Type 
Culture Collection and used over 15 passages. Cells were cultivated in Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with foetal bovine serum (FBS, 10 %), the antibiotics 
penicillin (100 IU/ ml) and streptomycin (100 μg/ml) as well as L-glutamine 20 mM and 
maintained at 37°C and 5% CO2. The culture medium was replaced every two to three days 
and the cells were passaged when they had reached approximately 90% confluence.   
Metabolic activity and transfection efficiency 
A549 cells were seeded in 24-well tissue culture plates (Nunc, UK) at a density of 5 × 104 cells/ 
well and incubated overnight in 0.5 mL of supplemented DMEM, after which they exhibited 
approximately 75% confluency. Polyplexes at the selected RU:Nt ratios with a final DNA 
concentration of 10 μg/ml were prepared and then added to OptiMEM® medium. The cell 
culture medium was aspirated and cells were rinsed with 0.5 ml of PBS before adding 
OptiMEM® (0.5 ml) containing the polyplexes. Four hours later, the polyplex suspension was 
removed and replaced with fresh serum-supplemented DMEM. After a 24-hour incubation, the 
cell metabolic activity and the polyplex transfection efficacy were assessed using a PrestoBlue® 
(PB) or luciferase assay, respectively.  
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For the PB assay, the medium was removed and cells were washed with PBS, then 250 µl of 
PB reagent in Hanks’ Balanced Salt solution HBSS (1:10) was added to each well. After 30-
minute incubation, 100 μl of supernatant was transferred into a black 96- well plate (Nunc, 
UK) and the fluorescence was measured by a TECAN Infinite® M200 plate reader (Männedorf, 
Switzerland) at an excitation and emission wavelength of 560 nm and 590 nm, respectively. 
The metabolic activity was calculated as a percentage relative to the activity in untreated 
control cells (100% metabolic activity). 
The remaining PB reagent was removed from all wells and cells were washed with PBS again 
before proceeding to the luciferase assay. 100 μl of Glo Lysis Buffer (1x) was added to each 
well and plates were incubated for 5 minutes at room temperature to allow cell lysis. 75 μl of 
cell lysate was transferred from the 24- well plate into a white 96- well plate (Nunc, UK) and 
an equal volume of luciferase assay reagent added to the cell lysate in each well. Finally, the 
luminescence was quantified using a TECAN Infinite® M200 plate reader with an integration 
time of 1 second. Untreated cells were used to determine the background readings. 
In order to assess the impact of endo/lysosomal escape on the rate of transfection, cells were 
pre-incubated with bafilomycin (500 nM) or chloroquine (100 µM) in OptiMEM® media at 
37°C for 30 min. The cells were then transfected with the polyplexes in presence of the drugs. 
The metabolic activity and transfection efficiency were measured 24 h later following the 
methods described above. The assays were performed on two independent occasions (n=3 wells 
for each experiment).   
Effect of free polymers and DNA polyplexes on cell membrane integrity    
An LDH release assay was performed to assess membrane integrity following cell exposure to 
the polyplexes. A549 cells were seeded in black 96-well plates at 15 × 103 cells/well. After 24 
h, cells were treated with a range of BPEI and PAA polymer concentrations (0.1, 1, 10, 100 
and 1000 μg/ml) or with selected polyplexes prepared as above. Untreated cells (spontaneous 
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LDH release), cells treated with 4% Triton X-100 (100% LDH release) and culture medium 
without cells were included as controls. After 4 h incubation, an equal volume of CytoTox-
ONE™ -reagent was added to each well and the plate was incubated at 25°C for 10 min. The 
reaction was terminated by addition of 50 μL Stop Solution (provided with the CytoTox-
ONE™ kit) to each well. The plate was then shaken for 10 seconds and the fluorescence was 
measured in a TECAN Infinite® M200 plate reader at an excitation wavelength of 560 nm and 
emission wavelength of 590 nm. The assay was carried out on two independent occasions (n=3 
wells per experiment).    
Mitochondrial membrane potential (MMP) measurement 
A549 cells were seeded at a density of 4 × 105 cells per well in 6-well plates and incubated for 
24 h before transfection. The cells were then treated with various polyplex formulations for 4 
h and with FCCP (10 µM) as a positive control for 10 minutes. The medium was replaced with 
fresh culture medium, and cells were incubated for an additional 20 h under standard cell 
maintenance conditions. The medium was removed and 2 ml of a 5 mM solution of JC-1 was 
added to each well and the cell culture plate was incubated for 30 min in the dark. Cells were 
harvested and the resulting suspension was measured by flow cytometry using a Beckman 
Coulter FC500. Red fluorescence (ex: 488 nm, em: 590 nm) was detected in FL2 and green 
fluorescence (ex: 488 nm, em: 527 nm) was observed in FL1 with 10,000 events captured for 
each sample. Data were analysed with the Weasel Flow Cytometry Software and are expressed 
as percentage of red/green fluorescence ratio. The assay was performed on two independent 
occasions (n=2 wells per experiment).   
Quantification of intracellular reactive oxygen species (ROS) 
Cells were seeded at a density of 15 × 103 cells/well in black 96-well plates and were incubated 
for 24 h. Cells were then exposed to H2DCF-DA (10 μM) in PBS for 45 min. The dye was 
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removed and the cells were washed with PBS and then incubated with various polyplex 
formulations for 4 h or with hydrogen peroxide (400 μM) as a positive control for 2 h. After 4 
h incubation, the fluorescence intensity was measured at 485 nm excitation and 535 nm 
emission with a TECAN Infinite® M200 plate reader. The generation of ROS in treated cells 
was expressed as a % increase above the ROS level in untreated cells (100% ROS). The assay 
was performed on two independent occasions (n=3 wells per experiment).   
Statistical analysis 
Student’s t-test or one-way ANOVA followed by a Tukey’s test were performed to compare 
two or multiple datasets, respectively, using Graphpad prism software version 7.0 (San Diego, 
California, USA). Statistical significance was established when p < 0.05.  
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Results   
Gel retardation assays 
Gel retardation assay is a simple technique used to assess the ability of polycations to complex 
nucleic acids. During electrophoresis, unbound polycations move towards the negative 
electrode and free nucleic acids migrate towards the positive electrode. 
PAA completely abolished pDNA migration at a RU:Nt of 2:1 as indicated by the 
disappearance of EtBr stained nucleic acids from the gel (Figure 2A, lower image). 
Nevertheless, EtBr fluorescence could be observed in the loading wells, implying that the dye 
was still able to intercalate between DNA base pairs and therefore, that tight binding of pDNA 
by the polymer was not achieved. In addition, free polymer started to appear at a 3:1 RU:Nt 
with polymer staining becoming more intense as the polymer/pDNA ratios increased (Figure 
2A, upper image). On the other hand, pDNA mobility was completely inhibited by BPEI at a 
RU:Nt of 3:1 and no discrete polymer or fluorescence staining was associated with the retarded 
polyplexes below a 30:1 ratio, indicating the ability of the polymer to bind strongly to pDNA 
to allow a large excess incorporation of polymer (Figure 2B).  
Based on the gel retardation observations, only polyplexes prepared at 2:1, 5:1 or 10:1 RU:Nt 
for PAA and 5:1 or 10:1 for BPEI were further explored. 
Size and zeta potential of the DNA polyplexes 
It is reported that a DNA polyplex size of less than 200 nm is required for efficient cellular 
uptake via endocytosis and subsequent transfection (5, 22). Both PAA and BPEI polymers 
formed polyplexes with a diameter around or below 200 nm (Figure 3A). 
The zeta potential reflects the surface charge of colloids. This is an important measurement as 
the surface charge of DNA polyplexes affects their colloidal stability and interactions with the 
negatively charged cell membranes (17, 23).  
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The zeta potential of PAA polyplexes was positive (> 30 mV) at all three RU:Nt investigated 
and was significantly raised when the ratio was increased from 2:1 to 5:1  to then reach a 
plateau at 10:1 (Figure 3B). This shows that the free polymer observed in the gel retardation 
assays at RU:Nt above 2:1 (Fig. 2A) contributes to the polyplex surface charge. BPEI 
polyplexes also exhibited a positive zeta potential value which, at the 10:1 RU:Nt, was 
significantly higher than that of the PAA polyplexes. This would be expected from the much 
higher excess of polymer which is able to bind to the pDNA (Figure 3B). 
Metabolic activity and transfection efficiency 
The cytotoxicity and gene transfection efficiency of PAA and BPEI based polyplexes were 
compared by performing a PB metabolic activity assay or a luciferase reporter gene assay, 
respectively.  
Cells exposed to PAA polyplexes at RU:Nt of 2:1 and 5:1 maintained a metabolic activity 
~90% of that in untreated cells, while a reduction to approximately 70% of controls was 
observed when cells were incubated with polyplexes at the highest RU:Nt (Figure 4A). In 
contrast, the cell metabolic activity dropped to ~30% of the level measured in control cells after 
exposure to BPEI polyplexes at the RU:Nt of 5:1 and 10:1 (Figure 4A).  
The luciferase activity measured in cells transfected with the PAA polyplexes was not affected 
by the RU:Nt (Figure 4B),  indicating that the presence of excess polymer had no impact on 
the transfection efficiency. With BPEI polyplexes, a peak in luminescence was obtained at the 
5:1 ratio (Figure 4B). The level of transgene expression achieved with BPEI polyplexes at the 
highest RU:Nt was greater than that obtained with the PAA vectors, despite their more 
pronounced cytotoxicity (Figure 4A). However, it is noteworthy that PAA polyplexes 
formulated at a 5:1 RU:Nt ratio  exhibited the same transfection efficiency as BPEI complexes 
at a 10:1 ratio but without any deleterious effects on the cells (Figure 4).  
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Effect of free polymers and polyplexes on cell membrane integrity    
The LDH assay was used to assess the integrity of the plasma membrane following cell 
treatment with either the free polymers or the polyplexes. LDH is a cytoplasmic enzyme that 
is released into the extracellular space when the cell membrane is damaged. The assay was 
performed after a 4h exposure in order to capture immediate effects.  
LDH released in response to the PAA polymer was negligible at all tested concentrations 
whereas BPEI showed a concentration dependent effect on the cell membrane with an EC50, 
i.e., the concentration that caused 50% LDH release as compared to the positive control Triton 
X, of 8.7 μg/ml (Figure 5 A).  
Again, cell exposure to PAA polyplexes did not induce any significant LDH release at any 
RU:Nt studied (Figure 5 B). In comparison, BPEI based vectors caused an extracellular leakage 
of the protein at the highest RU:Nt of 10:1 (Figure 5 B). 
Effect on the mitochondrial membrane potential  
The ability of the polyplexes to trigger apoptosis was determined through measurement of the 
mitochondrial membrane potential (MMP) in a JC-1 assay using FCCP as a positive control. 
The JC-1 probe is a cationic lipophilic dye which accumulates in the mitochondria where it 
forms aggregates (red fluorescence) at a high MMP. When MMP decreases during the early 
stages of apoptosis (22), the dye is converted into a monomeric form (green fluorescence).  
As shown in Figure 6, PAA polyplexes caused no detectable loss in MMP at any of the tested 
RU:Nt whereas a decrease in the red/green fluorescence of the JC-1 dye, indicative of a drop 
in MMP, was quantified after cell exposure to the  BPEI polyplexes. 
Intracellular formation of reactive oxygen species  
The generation of intracellular reactive oxygen species (ROS) after cell exposure to the 
polyplexes was probed using the H2DCF-DA dye. This is non-fluorescent but it is converted 
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into the highly fluorescent 2’,7’- dichlorofluorescein upon oxidation in the cell cytoplasm. 
H2O2 was used a positive control in the assay.  
Both types of polyplexes triggered ROS production but while the effect was observed at RU:Nt 
of 5:1 and 10:1 when those were prepared with BPEI, it was only apparent at the highest ratio 
with the  PAA polyplexes (Figure 7). 
Inhibition of endosomal acidification 
Bafilomycin A1 was co-incubated with PAA and BPEI polyplexes during transfection to 
investigate whether an influx of protons into the endosomes favours transgene expression. 
Bafilomycin A1 is a specific inhibitor of the Vacuolar-type H+-ATPase (V-ATPase) and 
therefore, prevents endosomal acidification (25-27). 
Bafilomycin A1 caused a dramatic reduction (> 75%) in the luciferase activity measured 
following transfection with the PAA polyplexes at all RU:Nt (Figure 8B). Similarly, the 
transfection efficiency of BPEI polyplexes was significantly decreased by ~50% and ~90 % at 
a 5:1 or 10:1 ratio, respectively (Figure 8B). Interestingly, the drug reversed the cytotoxic 
effects of the PAA polyplexes and the BPEI-based vectors at the lowest RU:Nt (Figure 8A). 
Inhibition of endo/lysosomal functions 
To assess the effect of lysosomes on transgene expression, A549 cells were transfected with 
PAA or BPEI polyplexes in presence of chloroquine. Chloroquine is a weak base that diffuses 
across membranes in its unprotonated form but upon protonation in the acidic environment of 
the endosomes and lysosomes, becomes trapped in the organelles (28-30). As a consequence, 
it raises their pH (32, 33), impairs the fusion of endosomes and lysosomes, and inhibits the 
degradative effects of some endosomal/lysosomal enzymes depending on their activity profile 
at a higher pH (34). 
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Co-incubation of the cells with PAA polyplexes at a 2:1 RU:Nt and chloroquine resulted in a 
3-fold increase in luciferase activity (Figure 9B). In contrast, the drug significantly decreased 
luciferase expression by 2- or 3.5-fold when the polyplexes were prepared at a 5:1 or 10:1 ratio, 
respectively (Figure 9B). Addition of chloroquine led to a 2.5-fold enhancement in the 
transfection efficiency of BPEI polyplexes at a 5:1 ratio, whereas no change in luciferase 
expression was observed at the 10:1 ratio (Figure 9B).  
As shown in Figure 9A, upon treatment with chloroquine, the metabolic activity of cells 
transfected with BPEI polyplexes at the 5:1 RU:Nt was increased as compared to that in cells 
exposed to the polyplexes alone. However, the drug had no effect on the metabolic activity 
when BPEI polyplexes at the highest ratio or when PAA polyplexes were used for transfection.   
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Discussion  
While it has been suggested the ability of conventional cationic polymers to promote transgene 
expression is linked to their cytotoxicity (7,8), certain members of the PAA class of polymers, 
such as the MBA-DMEDA structure (17) and the ISA series (14, 16), do not seem to follow 
such a trend and exhibit a relatively high transfection efficiency with minimal detrimental 
effects on the transfected cells. This study aimed to increase understanding of PAA promising 
behaviour in gene delivery by comparing cellular events occurring upon transfection with DNA 
polyplexes prepared using either a MBA-DMEDA based PAA with a molecular weight over 
10 kDa or BPEI of 25 kDa.  
As reported previously (17, 18), the optimal RU:Nt ratio for transfection with the PAA 
polyplexes was 5:1 (Fig.4 B). Nevertheless, at that ratio, a higher expression of the luciferase 
gene was observed when A549 cells were transfected with BPEI polyplexes than with their 
PAA counterparts. BPEI mediated efficient transfection despite the cell metabolic activity 
dropping to 30% of the control (Fig.4 A) but a further increase in polymer content within the 
polyplexes led to a reduction in luciferase expression (Fig. 4B), likely as a consequence of 
extensive cell death (Fig.4A). On the other hand, PAA polyplexes exhibited maximum 
transfection activity when cells maintained around 90% of their metabolic activity (Fig.4A & 
B). Those contrasting outcomes can be attributed to the intrinsic properties of the polymers 
since both types of polyplexes had a comparable size and zeta potential at the 5:1 RU:Nt 
(Fig.3). Interestingly, the excess of PAA polymer observed at that ratio (Fig.2) did not appear 
to contribute to the transfection efficiency or cause detectable cytotoxic effects. Nevertheless, 
an increase in free polymer at the higher 10:1 ratio, as evidenced by a more intense staining on 
the agarose gel (Fig. 2), had a negative impact on transgene expression, probably due to damage 
caused to the cells (Fig.4 and 7).  
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The absence of LDH release in the extracellular environment immediately post exposure of the 
cells to both types of polyplexes at a 5:1 RU:Nt (Fig.5) indicates that direct permeabilisation 
of the cell membrane is not a major mechanism driving gene expression and/or cytotoxicity. 
This is also in agreement with the polyplexes entering the cells via endocytotic processes, as 
reported for similar gene/protein delivery vehicles in various cell types (35-37).  
It is generally assumed that gene delivery systems have to escape the endosomes before they 
are degraded in the lysosomes (5). A ‘proton sponge effect’ triggered by the protonation of the 
polymer amine groups once inside the acidic environment of the endosomes and eventually 
causing the rupture of the vesicles has long been described as a possible mechanism of polyplex 
endosomal escape (5). Such a mechanism has nevertheless been recently disproved for PEI 
vectors (38). An alternative hypothesis has therefore been formulated suggesting that 
protonated polymers interact with the inner membrane of the endosomes and thus create pores 
allowing the release of the polyplexes into the cytoplasm (5). Overall, polyplex escape from 
the endosomes is a very inefficient process (5) and any factor affecting this might have a 
significant impact on the ability of cationic polymers to mediate transgene expression. 
Transfection of A549 cells in presence of the Vacuolar-type H+-ATPase (V-ATPase) pump 
inhibitor bafilomycin A1 demonstrated that acidification of the endosomes was critical for the 
induction of luciferase expression by both BPEI and PAA polyplexes (Fig.8). Bafilomycin had 
nevertheless a greater impact on the transfection efficiency of PAA/DNA complexes (Fig.8). 
PAAs have been reported to be subjected to an expansion of their coil structure at low pH as a 
result of electrostatic repulsion between protonated nitrogens (39, 40). Such a conformational 
reorganisation has been suggested to account for the dramatic enhancement in the polymer 
haemolytic activity observed at pH 5.5 as compared to pH 7.4 (14, 41), although the overall 
positive charge of the polymers at the lower pH might also contribute to cell membrane 
destabilisation (42). PLL and PEI, on the other hand, showed haemolytic properties at both a 
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neutral and acidic pH (14, 41). Although the PAA used in the present study was structurally 
different, this can explain why the polyplexes were more dependent on a drop in pH to evade 
the endosomes than their BPEI counterparts.  The BPEI repeating unit has a much lower 
molecular weight than that of PAAs (~40 vs ~210 Da) and features four independent protonable 
groups, whose protonation is affected by the protonation state of neighbouring sites (43). As a 
result, at any pH, the positive charge density of BPEI and thus, the polymer interactions with 
biological membranes are higher than for PAAs. 
Interestingly, co-incubation of A549 cells with BPEI polyplexes at the optimal RU:Nt ratio and 
bafilomycin reversed the reduction in metabolic activity caused by the polymeric DNA 
complexes alone, indicating that their cytotoxic effects mainly originate from their endosomal 
escape. BPEI polyplexes caused a significant reduction in MMP in the cell line (Fig.6), 
similarly to previous observations in Jurkat T and HeLa cells (19, 44) and stimulated the 
production of ROS (Fig.7). These phenomena are likely consequences of the polymer 
disruption of the mitochondrial membrane and/or a significant polymer induced leakage of 
endosomal content into the cytoplasm and will eventually lead to apoptosis (44). In contrast, 
PAA polyplexes did not affect the MMP (Fig.6) and only increased ROS cytoplasmic levels at 
the highest RU:Nt ratio (Fig.7), probably because the polymer is unable to interact with the 
membrane of organelles once released in the neutral cytoplasmic environment. This is 
supported by the absence of LDH release upon cell exposure to the polymer at pH 7.4 (Fig.5A). 
Furthermore, while leaky endo/lysosomal vesicles were isolated from hepatic cells after 
injection of the ISA1 PAA structure to rats, the polymer was unable to permeabilize naïve 
vesicles when it was added to the suspension medium, in contrast to PEI (23). Cytotoxicity 
data collected in this study also demonstrates PAA escape from the endosomes is not 
accompanied by acute adverse effects the cell is unable to compensate for, which suggests that 
any pores created in the endosomal membrane by the cationic polymer must be transient. A 
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chronic transfer of the endosomal content into the cytoplasm upon repeated cell exposure to 
the PAA vectors may nevertheless perturb their normal physiology and eventually induce long-
term toxic effects.   
Transfection in presence of chloroquine enhanced luciferase expression mediated by PAA 
polyplexes at a 2:1 RU:Nt and BPEI polyplexes at a 5:1 ratio (Fig.9), which indicates that under 
control transfection conditions, a significant fraction of the vectors are trafficked from the 
endosomes to the lysosomes where they are likely degraded. In the BPEI polyplex case, 
improved transfection coincided with a reduction in cytotoxicity and therefore, could also be a 
result of an increase in cell survival following partial inhibition of endo/lysosomal escape. 
Surprisingly, chloroquine had a negative impact on the transfection efficiency of PAA 
polyplexes at higher RU:Nt without affecting their cytotoxicity (Fig.9). It therefore seems that 
these vectors benefit from their progression into the late endosomes/lysosomes. It is possible 
that the excess polymer associated with the complexes requires a lower pH than in the early 
endosomes for membrane permeabilisation and/or DNA decomplexation. The pKa of the two 
tertiary amine groups of the repeating units of the polymer used in this study can be estimated 
as 4.9 and 8.4 (see ‘Materials’). Accordingly, it will indeed be more protonated and thus, more 
prone to interacting with biological membranes as the pH approaches its lower pKa value. 
Although the data reported herein would need to be confirmed in a range of cell culture models, 
overall they indicate that the MBA-DMEDA polymer promotes transgene expression through 
destabilisation of the endo/lysosomal membranes without this causing a significant acute 
toxicity to the cells. They are in line with conclusions drawn from cell-based and in vivo studies 
with other PAA structures that have shown transfection activity and/or ability to enhance the 
cellular effects of bacterial toxins (which, similarly to genetic materials need to escape the 
endosomal compartment before being degraded) (14, 23, 41, 45).   
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Conclusion  
This study confirms that PAAs with a MBA-DMEDA backbone are effective at mediating 
transgene expression in vitro without significant cytotoxicity at the concentration required for 
optimal transfection. It also shows that the transfection efficiency of those PAA polymers rests 
upon pH-dependent releases from both the early endosomes and late endosomes/lysosomes 
which, in contrast to BPEI vectors, do not induce pro-apoptotic events. Efficacy and safety 
need to be evaluated in vivo but overall, this work suggests that further development of MBA-
DMEDA as vectors for gene delivery might be worthwhile.   
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Figure legends  
 
Fig.1: Chemical structure of the MBA-DMEDA polymer used in this study 
Fig.2: Gel retardation of pDNA polyplexes prepared using (A) PAA (B) BPEI. (A) lane 1 
contains naked DNA only as a control, lanes 2-9 contain polyplexes with RU:Nt ratios of 1:1, 
2:1, 3:1, 4:1, 5:1, 6:1, 7:1 and 10:1, respectively and lane 10 contains polymer only as a control. 
(B) lanes 1 and 11 contain naked DNA only as a control, lanes 2-9 contain polyplexes with 
RU:Nt ratios of 1:1, 2:1, 3:1, 4:1, 5:1, 6:1, 7:1, 10:1, lanes 12-19 contain polyplexes with RU:Nt 
ratios of 2:1, 5:1, 10:1, 15:1, 20:1, 30:1, 40:1, 50:1 and lanes 10 and 20 contain polymer only 
as a control. For each gel displayed, the upper image shows the migration of the polymer 
towards the negative electrode, while the lower image shows the migration of DNA towards 
the positive electrode. 
Fig.3: (A) Hydrodynamic diameter (nm) and (B) Zeta potential measurements for pDNA 
polyplexes prepared using PAA and BPEI at different RU:Nt ratios (2:1, 5:1 and 10:1) in PBS 
solution. * indicates a statistically significant difference between zeta potential values 
determined by one-way ANOVA and a Tukey's multiple comparison post-hoc test (***p < 
0.001; ****p < 0.0001) 
Fig.4: (A) Metabolic activity and (B) Transfection efficiency measured by a Presto Blue or 
luciferase assay, respectively, 20h following cell exposure to DNA polyplexes for 4 hours. The 
data are expressed as mean ± SD (3 replicates, n=2). * indicates statistically significant 
differences, as determined by one-way ANOVA and a Tukey's multiple comparison post-hoc 
test (*p < 0.05; **p< 0.01; ****p < 0.0001).    
Fig.5: (A) Dose-response curve showing LDH released from A549 cells treated with increasing 
concentrations of BPEI or PAA polymers for 4 h. Data represents the mean mean ± SD (6 
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replicates, n = 2);  (B) LDH released from A549 cells following exposure to PAA and BPEI 
polyplexes for 4 h. The data are expressed as mean ± SD (3 replicates, n=2). * indicates a 
statistically significant release compared to untreated cells, as determined by one-way ANOVA 
and a Tukey's multiple comparison post-hoc test. (****p < 0.0001).  
Fig.6: MMP measured 20 h following A549 cell exposure to PAA and BPEI polyplexes for 4 
hours using the JC-1 dye. Cells were treated with 10 μM FCCP as a positive control. The data 
are expressed as mean ± SD (2 replicates, n=2). * indicates a statistically significant decrease 
in the % red/green fluorescence ratio compared to untreated cells, as determined by one-way 
ANOVA and a Tukey's multiple comparison post-hoc test (****p < 0.0001).    
Fig.7: Intracellular ROS production measured in A549 cells exposed for 4 hours to PAA and 
BPEI polyplexes using the H2DCF-DA dye. Cells were treated with 400 μM hydrogen 
peroxide (H2O2) as a positive control. The data are expressed as mean ± SD (3 replicates, n=2). 
* indicates a statistically significant increase in ROS levels compared to untreated cells, as 
determined by one-way ANOVA and a Tukey's multiple comparison post-hoc test (**p< 0.01; 
***p < 0.001; ****p < 0.0001).    
Fig.8: Effect of bafilomycin A1 (500 nM) on (A) the metabolic activity and (B) the transfection 
efficiency measured by a Presto Blue or luciferase assay, respectively 20h following exposure 
of A549 cells to PAA and BPEI polyplexes for 4 hours. The data are expressed as mean ± SD 
(3 replicates, n=2). * indicates a statistically significant difference from the control condition 
in absence of inhibitor, as determined by a two-tailed Student’s t-test (**p< 0.01; ****p< 
0.0001).    
Fig.9: Effect of chloroquine (100 µM) on (A) the metabolic and activity and (B) the 
transfection efficiency measured by a Presto Blue or luciferase assay, respectively 20h 
following cell exposure to PAA and BPEI polyplexes for 4 hours. The data are expressed as 
mean ± SD (3 replicates, n=2). * indicates a statistically significant difference from the control 
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condition in absence of inhibitor, as determined by two-tailed Student’s t-test (**p< 0.01; 
***p< 0.001).    
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Figure 1, Almulathanon et al 
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Figure 2, Almulathanon et al 
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Figure 5, Almulathanon et al  
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Figure 6, Almulathanon et al 
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Figure 7, Almulathanon et al 
 
  
2
:1
5
:1
1
0
:1
5
:1
1
0
:1
0
1 0 0
2 0 0
3 0 0
4 0 0
P o ly m e r  to  n u c le o t id e  ( R U :N t )  r a t io s
I
n
t
r
a
c
e
ll
u
la
r
 R
O
S
 l
e
v
e
l 
(
%
)
P A A
B P E I
H 2 O 2
U n t r e a t e d  c e l l s
****
**
***
****
36 
 
Figure 8, Almulathanon et al 
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Figure 9, Almulathanon et al 
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